News | May 03, 2021
Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
A pharma industry veteran with over three decades of experience in domestic as well as international markets
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
ICICI Direct gives a preview on the earnings narrative for Q3FY22
Subscribe To Our Newsletter & Stay Updated
